SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-2.27 Cr | ₹-2.31 Cr | ₹-1.26 Cr | - |
What is the latest Deferred Tax Assets / Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-2.27 Cr |
| Mar2025 | ₹-2.31 Cr |
| Mar2024 | ₹-1.26 Cr |
| Mar2023 | - |
How is Deferred Tax Assets / Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2.27 Cr | Negative | |
| Mar2025 | ₹-2.31 Cr | Negative | |
| Mar2024 | ₹-1.26 Cr | 0 | |
| Mar2023 | - | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,303.4 Cr | -3.2% | -1.3% | 51.9% | Stock Analytics | |
| PRIME FOCUS | ₹23,491.7 Cr | -0.9% | 9.7% | 65.6% | Stock Analytics | |
| SAGILITY | ₹20,185.9 Cr | -4.7% | -9% | -1.2% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹14,570.4 Cr | -4.1% | -9% | -42.6% | Stock Analytics | |
| INDEGENE | ₹14,313.4 Cr | -0.5% | -3.6% | 5.6% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹13,483.4 Cr | -2.8% | -7.4% | -10.8% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -3.2% |
-1.3% |
51.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses